Trial intelligence / Profile preview

Inhibition of Dental Plaque Regrowth by an Ethanol-Free 0.2% Chlorhexidine Mouth Rinse

2006-005953-31Phase 4Completed

Sponsor
GSK
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in dental plaque and gingivitis comparing Chlorhexidine 0.2% mouthrinse arm with Placebo mouthrinse arm (2 arms). Primary endpoint: Dental plaque regrowth (Quigley-Hein Index, Turesky modification). Started Aug 2007; status: completed.

02

Drugs

chlorhexidine
03

Conditions

dental plaquegingivitis

Beyond the preview

Go deeper on 2006-005953-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005953-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call